Yahya SalemCEO & Founder at YATREXPresenter
Profile
Yahya Salem is the Founder and CEO of YATREX, a Luxembourg biopharmaceutical company developing novel therapeutics for ischemic stroke and reperfusion injury. He leads the company's scientific and business strategy, spanning drug discovery, intellectual property, translational development, and partnering. Yahya has multidisciplinary experience in neuropharmacology, medicinal chemistry, ion channel pharmacology, and translational neuroscience through research positions at the Luxembourg Centre for Systems Biomedicine, the Korea Institute of Science and Technology, Edinburgh Napier University, and Swinburne University of Technology. His work focuses on translating innovative science into first-in-class therapeutic opportunities through strategic collaborations with pharmaceutical partners.